OPNT - Opiant Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
No. of Analysts3023
Avg. Estimate-2.102.13-0.29
Low Estimate-702.05-2.65
High Estimate0.602.223.21
Year Ago EPS-0.37-0.44-7.12.13
Revenue EstimateCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
No. of Analysts3033
Avg. Estimate7.63MN/A40.48M28.65M
Low Estimate7.3MN/A40.15M23.05M
High Estimate8.1MN/A40.9M36.8M
Year Ago Sales4.76MN/A13.98M40.48M
Sales Growth (year/est)60.20%N/A189.50%-29.20%
Earnings History12/30/20183/30/20196/29/20199/29/2019
EPS Est.-0.13-0.79-0.55-0.09
EPS Actual-0.37-0.440.311.97
Difference-0.240.350.862.06
Surprise %-184.60%44.30%156.40%2,288.90%
EPS TrendCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
Current Estimate-2.102.13-0.29
7 Days Ago-2.102.13-0.29
30 Days Ago-2.102.13-0.29
60 Days Ago-2.102.13-0.29
90 Days Ago-2.102.13-0.29
EPS RevisionsCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesOPNTIndustrySectorS&P 500
Current Qtr.-467.60%N/AN/A0.00
Next Qtr.N/AN/AN/A0.08
Current Year130.00%N/AN/A0.01
Next Year-113.60%N/AN/A0.15
Next 5 Years (per annum)N/AN/AN/A0.08
Past 5 Years (per annum)N/AN/AN/AN/A